RxDoctor Payments Data

Brittany Eaker

Family · Gastonia, NCNPI 1326696782

Payments from drug & device makers

$1,848in general payments, 2019–2025

Across 64 payments — averaging $28.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$486
  • Biosense Webster, Inc.$401
  • Boston Scientific$300
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$254
  • Altathera Pharmaceuticals LLC$119
  • Inspire Medical Systems, Inc.$106
  • plus $182 from 3 others

What the payments were for

  • Food & beverage$1,74995%
  • Education$995%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,848 in reported general payments places this provider in the 80th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$19,673
Medicare patients
176
Services billed
371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban265$214,208
XareltoRivaroxaban67$53,483
Dofetilide184$20,626
EntrestoSacubitril/Valsartan14$10,624
Flecainide Acetate122$2,979
Amiodarone Hcl125$2,919
SotalolSotalol Hcl157$1,784
Metoprolol Succinate121$1,464
Diltiazem 24hr Er (Cd)Diltiazem Hcl37$1,056
Potassium Chloride36$340
Carvedilol50$251
Atorvastatin Calcium27$167
Metoprolol Tartrate50$161
ClopidogrelClopidogrel Bisulfate14$149
Digoxin12$130

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$214,208265 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,522 family providers in North Carolina.

Other family in Gastonia

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →